Doxycycline: clinical trials recruiting now
FDA drug label
- FDA-approved
- Yes. Doxycycline appears in the FDA drug-label database. Marketed as DOXYCYCLINE.
- Drug class
- Tetracycline-class Drug (FDA established pharmacologic class)
FDA-approved use
To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline is indicated for the treatment of the following infections: Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis. Psittacosis (ornithosis) caused by Chlamydophila psittaci. Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis. Uncomplicated urethral, endocervical or rectal infections in adults caused by Chlamydia trachomatis. Nong…
FDA recalls / enforcement
| Reason (FDA) | Classification | Status | Initiated |
|---|---|---|---|
| Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result. — West-Ward Columbus Inc | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2020-05-13 |
| Failed Dissolution Specifications: — West-Ward Columbus Inc | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2018-07-24 |
| Failed Dissolution Specifications: — West-Ward Columbus Inc | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2018-07-24 |
| CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — CARDINAL HEALTHCARE | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2022-01-26 |
| CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions. — Sun Pharmaceutical Industries, Inc. | Class II (FDA: may cause temporary or reversible harm) | Terminated | 2020-03-13 |
Phase breakdown
Conditions being studied
Recruiting trials involving Doxycycline
- Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
- Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
- Effects of Treatments on Atopic Dermatitis
Common questions
Is Doxycycline FDA-approved?
Yes, marketed as DOXYCYCLINE.
How many recruiting trials involve Doxycycline?
3 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.